ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 140 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hennion & Walsh Asset Management, Inc. | 102,413 | $976 | 0.06% |
Virtus ETF Advisers LLC | 10,172 | $96,939 | 0.06% |
Tekla Capital Management LLC | 148,874 | $1,418,769 | 0.06% |
Weiss Multi-Strategy Advisers LLC | 268,947 | $2,563 | 0.05% |
PROFUND ADVISORS LLC | 89,780 | $855,603 | 0.05% |
MARSHALL WACE, LLP | 2,317,541 | $22,086,166 | 0.04% |
Quantamental Technologies LLC | 10,304 | $98,197 | 0.04% |
Perceptive Advisors | 300,000 | $1,417,500 | 0.04% |
JENNISON ASSOCIATES LLC | 4,293,966 | $40,921,495 | 0.03% |
Rafferty Asset Management, LLC | 499,922 | $4,764,257 | 0.03% |
SECTORAL ASSET MANAGEMENT INC | 14,287 | $136,155 | 0.02% |
Caption Management, LLC | 135,000 | $1,286,550 | 0.02% |
E Fund Management Co., Ltd. | 26,877 | $256 | 0.02% |
Centiva Capital, LP | 90,000 | $857,700 | 0.02% |
Virtu Financial LLC | 21,769 | $207 | 0.02% |
Ensign Peak Advisors, Inc | 832,540 | $7,934,106 | 0.02% |
PICTET ASSET MANAGEMENT SA | 1,327,029 | $12,646,586 | 0.02% |
AXA S.A. | 448,642 | $4,275,558 | 0.01% |
Caption Management, LLC | 85,000 | $810,050 | 0.01% |
CANTOR FITZGERALD, L. P. | 56,903 | $542,286 | 0.01% |
External links
This page lists ARCUTIS BIOTHERAPEUTICS INC's shareholders in Q2 2023. To view ARCUTIS BIOTHERAPEUTICS INC's shareholder history, click here.